Data of S&P BSE Healthcare Index, Collected from Bombay stock exchange of India

India BSE Limited: Index: S&P BSE Healthcare data was reported at 42,564.180 NA in 15 May 2025. This records an increase from the previous number of 42,262.980 NA for 14 May 2025. India BSE Limited: Index: S&P BSE Healthcare data is updated daily, averaging 15,438.420 NA from Jan 2012 (Median) to 15 May 2025, with 3311 observations. The data reached an all-time high of 45,648.220 NA in 02 Jan 2025 and a record low of 5,861.140 NA in 02 Jan 2012. India BSE Limited: Index: S&P BSE Healthcare data remains active status in CEIC and is reported by Exchange Data International Limited. The data is categorized under High Frequency Database’s Financial and Futures Market – Table IN.EDI.SE: BSE Limited: S&P/BSE.

Analysis of ‘NIFTY-50 Stocks Dataset’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://www.kaggle.com/iamsouravbanerjee/nifty50-stocks-dataset on 28 January 2022.

--- Dataset description provided by original source is as follows ---

Context

The NIFTY 50 is a benchmark Indian stock market index that represents the weighted average of 50 of the largest Indian companies listed on the National Stock Exchange. It is one of the two main stock indices used in India, the other being the BSE SENSEX.

Nifty 50 is owned and managed by NSE Indices (previously known as India Index Services & Products Limited), which is a wholly-owned subsidiary of the NSE Strategic Investment Corporation Limited. NSE Indices had a marketing and licensing agreement with Standard & Poor's for co-branding equity indices until 2013. The Nifty 50 index was launched on 22 April 1996, and is one of the many stock indices of Nifty.

The NIFTY 50 index has shaped up to be the largest single financial product in India, with an ecosystem consisting of exchange-traded funds (onshore and offshore), exchange-traded options at NSE, and futures and options abroad at the SGX. NIFTY 50 is the world's most actively traded contract. WFE, IOM, and FIA surveys endorse NSE's leadership position.

The NIFTY 50 index covers 13 sectors (as of 30 April 2021) of the Indian economy and offers investment managers exposure to the Indian market in one portfolio. Between 2008 & 2012, the NIFTY 50 index's share of NSE's market capitalization fell from 65% to 29% due to the rise of sectoral indices like NIFTY Bank, NIFTY IT, NIFTY Pharma, NIFTY SERV SECTOR, NIFTY Next 50, etc. The NIFTY 50 Index gives a weightage of 39.47% to financial services, 15.31% to Energy, 13.01% to IT, 12.38% to consumer goods, 6.11% to Automobiles a and 0% to the agricultural sector.

The NIFTY 50 index is a free-float market capitalization weighted index. The index was initially calculated on a full market capitalization methodology. On 26 June 2009, the computation was changed to a free-float methodology. The base period for the NIFTY 50 index is 3 November 1995, which marked the completion of one year of operations of the National Stock Exchange Equity Market Segment. The base value of the index has been set at 1000 and a base capital of ₹ 2.06 trillion.

Content

In this Dataset, we have records of all the NIFTY-50 stocks along with various parameters.

Important Note

• % change is calculated with respect to adjusted price on ex-date for Dividend, Bonus, Rights & Face Value Split.
• 52 weeks high & 52 week low prices are adjusted for Bonus, Split & Rights Corporate actions.
• 365 days % Change and 30 days % Change values are adjusted With respect to corporate actions.

Acknowledgements

For more, you can visit the website of the National Stock Exchange of India Limited (NSE): https://www1.nseindia.com/

--- Original source retains full ownership of the source dataset ---

L'indice principal du marché boursier indien, le SENSEX, est tombé à 80544 points le 6 août 2025, perdant 0,21% par rapport à la séance précédente. Au cours du dernier mois, l'indice a baissé de 3,47%, bien qu'il soit encore 1,35% plus élevé qu'il y a un an, selon les transactions sur un contrat de différence (CFD) qui suit cet indice de référence indien. Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Inde - Bourse des Valeurs.

BackgroundPoor central nervous system penetration of cytotoxic drugs due to the blood brain barrier (BBB) is a major limiting factor in the treatment of brain tumors. Most recurrent glioblastomas (GBM) occur within the peritumoral region. In this study, we describe a hyperthemic method to induce temporary disruption of the peritumoral BBB that can potentially be used to enhance drug delivery.MethodsTwenty patients with probable recurrent GBM were enrolled in this study. Fourteen patients were evaluable. MRI-guided laser interstitial thermal therapy was applied to achieve both tumor cytoreduction and disruption of the peritumoral BBB. To determine the degree and timing of peritumoral BBB disruption, dynamic contrast-enhancement brain MRI was used to calculate the vascular transfer constant (Ktrans) in the peritumoral region as direct measures of BBB permeability before and after laser ablation. Serum levels of brain-specific enolase, also known as neuron-specific enolase, were also measured and used as an independent quantification of BBB disruption.ResultsIn all 14 evaluable patients, Ktrans levels peaked immediately post laser ablation, followed by a gradual decline over the following 4 weeks. Serum BSE concentrations increased shortly after laser ablation and peaked in 1–3 weeks before decreasing to baseline by 6 weeks.ConclusionsThe data from our pilot research support that disruption of the peritumoral BBB was induced by hyperthemia with the peak of high permeability occurring within 1–2 weeks after laser ablation and resolving by 4–6 weeks. This provides a therapeutic window of opportunity during which delivery of BBB-impermeant therapeutic agents may be enhanced.Trial RegistrationClinicalTrials.gov NCT01851733

Quality assessment of primary studies included in the systematic review and meta-analysis of breast self-examination practice and determinants among HCW in Ethiopia, 2020.